Keyphrases
Treatment Efficacy
100%
Methotrexate Treatment
100%
Level Change
100%
High-dose Methotrexate (HD-MTX)
100%
Tubal Ectopic Pregnancy
100%
Serum Human Chorionic Gonadotropin
100%
Human Chorionic Gonadotropin
70%
Merck
30%
Research Funding
20%
Methotrexate
20%
Positive Predictive Value
20%
Negative Predictive Value
20%
Reassurance
20%
Competing Interests
20%
Honorarium
20%
National Institute for Health Research
10%
Bioscience
10%
Multicenter Randomized Controlled Trial
10%
Likelihood Ratio
10%
Treatment Failure
10%
Prospective Cohort Study
10%
Placebo
10%
Medical Research Council
10%
Between-day
10%
Current Guidelines
10%
Test Threshold
10%
Success Probability
10%
Declare
10%
Setting Method
10%
Early Indicators
10%
Mechanism Evaluation
10%
NHMRC
10%
Gefitinib
10%
Evaluation Program
10%
Efficacy Evaluation
10%
Pharma
10%
Travel Support
10%
Optimal Test
10%
Intervention Bias
10%
AbbVie
10%
Health Research Partnerships
10%
Influence Evaluation
10%
Guerbet
10%
Galvani
10%
Social Sciences
Best-Worst Method
100%
UK
50%
Research Councils
50%
Legal Procedure
50%
Health Research
50%
Randomized Controlled Trial
50%
Medical Research
50%
Secondary Analysis
50%
Program Evaluation
50%
Authors
50%
Nursing and Health Professions
Methotrexate
100%
Ectopic Pregnancy
100%
Single Drug Dose
100%
Chorionic Gonadotropin
100%
Practice Guideline
11%
Predictive Value
11%
Research Funding
11%
Positive and Negative Predictive Values
5%
Placebo
5%
Diagnosis
5%
Prospective Cohort Study
5%
Program Evaluation
5%
Gefitinib
5%
Biochemistry, Genetics and Molecular Biology
Single Drug Dose
100%
Methotrexate
100%
Human Chorionic Gonadotropin
100%
Reassurance
11%
Randomized Controlled Trial
5%
Prospective Cohort Study
5%
Gefitinib
5%
Pharmacology, Toxicology and Pharmaceutical Science
Methotrexate
100%
Ectopic Pregnancy
100%
Chorionic Gonadotropin
100%
Randomized Controlled Trial
5%
Placebo
5%
Prospective Cohort Study
5%
Gefitinib
5%
Economics, Econometrics and Finance